Actively Recruiting

Age: 18Years +
All Genders
ID04776642

Arrhythmia and Conduction Disorders Toward Pathophysiology Based Treatment ADAPT Biobank

Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2024-01-25

1000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are collecting body materials and data from patients with or at risk of cardiac arrhythmias who have undergone or will undergo invasive or non-invasive treatments. The goal is to create a detailed collection of patient information to support research and improve understanding of the complex causes, varied clinical presentations, and outcomes of different arrhythmias. This effort aims to help identify patient subgroups for personalized treatment and prevention strategies. The study involves gathering bodily materials such as blood, left atrial appendage tissue, and various fat patches for biochemical marker assessments, histological, and molecular analyses related to cardiac arrhythmias. It includes patients participating in linked clinical trials and those undergoing cardiothoracic surgery. Different groups focus on specific types of arrhythmias, imaging studies, or tissue donations. Participants contribute clinical data and samples that are connected with their medical records for ongoing follow-up. Researchers monitor outcomes like new onset atrial fibrillation and recurrence of cardiac arrhythmia over a five-year period. The biobank supports long-term research by providing valuable materials and information to study the disease process and improve diagnosis, prevention, and treatment.

CONDITIONS

Brief Title

Biobank for "Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment"

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients visiting the AMC outpatient clinic
  • Patients included in ongoing or future clinical trials linked to this biobank, including MARK AF, INDICO AF, PREDICT AF, WEIGHTLOSS AF, MAD AF
  • Patients with cardiac arrhythmias such as supraventricular tachycardia (including atrial fibrillation, atrial tachycardia, atrial flutter, AVNRT, AVRT)
  • Patients with ventricular tachycardia (including ventricular tachycardia, ventricular flutter, ventricular fibrillation)
  • Patients with bradycardia (sinus node dysfunction, AV node dysfunction, interventricular conduction disorder)
  • Patients with arrhythmogenic cardiomyopathies (dilated cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy)
Not Eligible

You will not qualify if you...

  • Age under 18 years
  • Unable or unwilling to comply with study procedures
  • Pregnancy or of childbearing potential without adequate contraception
  • New York Heart Association (NYHA) class IV heart failure symptoms or left ventricular ejection fraction less than 35%

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Sample Collection

Duration - At the time of cardiothoracic surgery or thoracoscopic atrial fibrillation ablation surgery

Participants provide bodily materials including blood and tissue samples for biochemical marker assessments and molecular analyses related to cardiac arrhythmias.

1 to 2 visits depending on surgery or procedure

Long-term Monitoring

Duration - Up to 5 years

Participants' clinical data and medical records are linked for longitudinal follow-up to study the course and outcomes of cardiac arrhythmias.

Follow-up visits aligned with routine clinical care

Trial Site Locations

Total: 1 location

1

Amsterdam University Medical Center location AMC

Amsterdam, Netherlands

Actively Recruiting

Loading map...

Research Team

E

Elise Hulsman, Bc RN

J

Joris de Groot, MD, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

7

Similar Trials

The AVEIR DR Coverage With Evidence Development (DRIVE) Stud...

Cardiac Pacemaker

Actively Recruiting

1 location

Aveir Dual-Chamber Leadless Pacemaker Real-World Evidence Po...

Cardiac Pacemaker

Actively Recruiting

1 location

Aveir Single-Chamber Leadless Pacemaker Coverage With Eviden...

Cardiac Pacemaker

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here